Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A
- 3 January 2019
- journal article
- research article
- Published by Elsevier BV in Thrombosis Research
- Vol. 174, 151-162
- https://doi.org/10.1016/j.thromres.2018.12.027
Abstract
No abstract availableKeywords
Funding Information
- Baxalta (H15-29403)
This publication has 40 references indexed in Scilit:
- Guidelines for the management of hemophiliaHaemophilia, 2012
- A randomized comparison of two prophylaxis regimens and a paired comparison of on‐demand and prophylaxis treatments in hemophilia A managementJournal of Thrombosis and Haemostasis, 2012
- Evaluation of the TCIWorks Bayesian computer program for estimation of individual pharmacokinetics of FVIIIHaemophilia, 2010
- Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia AHaemophilia, 2010
- A Limited Sampling Strategy for Estimating Individual Pharmacokinetic Parameters of Coagulation Factor VIII in Patients With Hemophilia ATherapeutic Drug Monitoring, 2007
- In vivorecovery of factor VIII and factor IX: intra‐ and interindividual variance in a clinical settingHaemophilia, 2006
- The target jointHaemophilia, 2004
- Immature articular cartilage is more susceptible to blood‐induced damage than mature articular cartilage: An in vivo animal studyArthritis & Rheumatism, 2003
- Improved cost‐effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia AHaemophilia, 1997
- A calculator program for clinical application of the Bayesian method of predicting plasma drug levelsComputer Programs in Biomedicine, 1985